Babak Kateb, MD, is a neuroscientist whose research focuses on introducing advanced diagnostics and therapeutics into clinical neuroscience to rapidly identify and treat neurological disorders such as brain cancer, Alzheimer’s disease, Parkinson’s disease, and brain and spinal disorders. He did his clinical research fellowship at the USC Keck School of Medicine and studied neuroengineering at USC Ming Hsieh Institute. Dr. Kateb is founding chairman and CEO of the Society for Brain Mapping & Therapeutics (SBMT), president and scientific director of the Brain Mapping Foundation, director of the National Center for Nano-Bio-Electronics. He collaborates with Los Alamos National Lab and had an appointment with NASA/JPL as a visiting scientist. Previously Dr. Kateb was director of R&D at the Department of Neurosurgery at City of Hope Cancer Center and a research scientist at Cedars-Sinai Medical Center, where he developed a partnership between Cedars-Sinai and NASA. He received a NASA Tech Brief Award for his pioneering work on sniffing cancer cells using NASA’s electronic nose and the 2015 SBMT Pioneer in Medicine award. He is editor of The Textbook of Nanoneuroscience and Nanoneurosurgery, and editor of Neurophotonics and Brain Mapping. Currently, he is the Scientific Director and Director of Strategic Alliance at the California Neurosurgical Institute.
Brain cancer, Alzheimer’s disease, Parkinson’s disease, and other brain and spinal disorders
Dr. Ricardo Maccioni is a Professor of Neurology and Neurosciences, University of Chile. Currently, Director of the Laboratory of Neurosciences & Scientific Director of the ICC. He has served as Professor at the University of Colorado Medical School, U.S.A. He received his doctoral degree in 1975, and was a postdoctoral fellow at the NIH and CU Med Sch, Denver, U.S.A. and a visiting scholar at the Max Plank Institute in Germany. He is a world class scientist that has made some of world leading contributions to the study of Alzheimer’s disease (AD) and consciousness phenomenon. His discoveries on the role of tau protein, his neuroimmunomodulation theory of neurodegenerative disorders, design of a new in vivo neuroimaging technology, markers for its early diagnosis and innovative approaches for the treatment of AD, are among major contributions. He has served as Senior and Regional Editor of the Journal of Alzheimer´s Disease, and boards of Alzheimer´s Reports, Open Neurology, Journal of Neurochemistry, Therapeutic Advances in Chronic Diseases, Frontiers in Dementia, Archives of Medical Research and other. Co-author with George Perry of the book “Current Hypotheses and Research Milestones in Alzheimer´s Disease”, among other 12 books in the medical field. Considered by the scientific community as a natural leader for his high-impact publications, but also for directing global projects for science development and human welfare.
Dr. Pant received his M.A. and Ph.D. degrees in Physics from Agra University, Agra, India. His postdoctoral studies were conducted on the mechanisms of electron and ion transport in model membrane systems at the Department of Biophysics at Michigan State University. He joined the Laboratory of Neurobiology in the NIMH as a senior staff fellow in 1974 with Dr. Ichiji Tasaki where he studied the function of the axonal cytoskeleton in the squid giant axon. In 1979 he moved to the NIAAA extending his studies on the neuronal cytoskeleton and the effects of alcohol on its regulation. Dr. Pant moved to the NINDS, Laboratory of Neurochemistry in 1987 where he is presently chief of the section on Cytoskeleton Regulation. His laboratory is studying the mechanisms of topographic regulation of neuronal cytoskeleton proteins by post-translational modification, including the role of kinase cascades in normal brain and during neurodegeneration.
Jayme Strauss MSN, RN, MBA, SCRN is the Director of Neuroscience Clinical and Business Operations at Baptist Health South Florida located in Miami, FL. She supports the neuroscience service line throughout the organization which is comprised of 9 hospitals. She received her BSN from Cedar Crest College in Allentown Pennsylvania, and her MSN and MBA at Grand Canyon University in Phoenix. Jayme also is an adjunct clinical professor of Nursing at Barry University in Miami shores, FL. She holds her Stroke Certified Registered Nurse. She has eight years of acute neuro experience including: Trauma Neuro ICU, Neuro ICU, Neuro Progressive Care, and Neuroscience Telemetry as a bedside clinician, manager, professor, and administrator. In Jayme’s current role she is responsible for all clinical and business operations of the Neuroscience Service Line including The Joint Commission Comprehensive Stroke Center, NAEC Certified Level 4 Epilepsy Center, and first ABRET accredited Intraoperative Neuromonitoring Center in Florida. In addition she supports nursing functions for rehab and imaging, neuroscience research, EEG, and acute care neurosurgery program.
Panteleimon Giannakopoulos was born in 1965 in Greece. He obtained his MD degree in the University of Athens in 1989 before completing a full training on psychiatry and psychotherapy in London (Maudsley Hospital and Geneva) as well as postdoc training in Paris (La Pitié-Sâlpetrière Hospital, Federation of Neurology). In 1998, aged 33 years, he has been appointed as associate professor and medical head of the Division of Geriatric Psychiatry of the University Hospitals of Geneva. Later on (2004) he obtained the position of full tenured professor of Psychiatry in the University of Geneva. From 2003 to 2011, he also assumed a parallel position of full professor of Old Age Psychiatry in the University of Lausanne in order to promote the academic careers of junior staff locally. He has been Chairman of the Department of Mental Health and Psychiatry in Geneva for ten years (2005-2015) and vice dean of the Faculty of Medicine in the University of Geneva in charge of postgraduate and continuous education (2003-2011). From December 1st 2015, he is the medical head of the forensic psychiatry development in Geneva country. Specialist of Alzheimer disease research, he published more than 240 peer-reviewed articles in the field of neurobiology of aging with particular focus on predictive biomarkers of cognitive decline.
Rodney O. Leacock, M.D., neurointensivist at Palmetto Health Neurosurgery Associates, is board certified in neurology, neurocritical care and vascular neurology. Leacock received his medical degree from Howard University College of Medicine in Washington, D.C. and completed his neurology residency at Temple University Hospital in Philadelphia, Pennsylvania. He went on to complete a fellowship in neurocritical care at Wayne State University, Detroit Receiving Hospital in Detroit, Michigan and a stroke fellowship at Saint Louis University in Saint Louis, Missouri. His clinical interests include acute ischemic stroke, intracranial and subarachnoid hemorrhage, status epilepticus, and airway protection in patients with neurological disorders. He specializes in caring for patients with complex neurological diseases.
Jerzy Leszek is full professor of psychiatry at the Medical University in Wroclaw , Poland ,vice –director of the Psychiatry Department and head of Alzheimer’s Disease Lab. He is author and co-author more than 210 papers (especially from old age psychiatry), some chapters to the books published in reputed Polish and international journals and serving as an editorial board member of several journals .He is Scientific Editor and co-author of first Polish academic handbook on Alzheimer’s disease and seven another academic handbooks from psychogeriatry , member a lot of scientific associations eg founder and president of Lower Silesian Association of Alzheimer’s Families, first of its kind in Poland and Former Member of Board of Directions of International Psychogeriatric Association and President of Polish Psychogeriatric Association.
Thomas Feiner is an Occupational therapist, neurofeedback teaching therapist certified by the Biofeedback Certification International Alliance BCIA. He is also the Technical Director and Director of the Institute for EEG Neurofeedback (Munich)
Walter Bini has completed his Diploma at Westminster School, Simsbury Conn. USA and Post-graduate degree at Universidad de Zaragoza, Facultad de Medicina, Zaragoza-Spain. In 2014, he was the Middle East Chairman of ISLASS. He was Head of Neurosurgery at Sheikh Khalifa General Hospital, UAQ-UAE from 2014-2016. Currently, he is Consultant Neurosurgeon in Orthopedic department, spine section of Lanzo Hospital COF, Lanzo d’Intelvi in Italy and also Visiting Consultant Neurosurgeon in Orthopedic department at Healthpoint Hospital, UAE.
Soraya L Valles graduated in Biological Science at the University of Valencia in 1985 and in 1996 she finished her PhD in the IIC Institute looking for astrogliogenesis during brain development. In 1997 she spent three years at Hallamshire Hospital, Sheffield, UK. She was working in inflammation and regulation of IL-1 and IL-1 receptor. In 2000 she returned to Spain at Department of Physiology, Faculty of Medicine in University of Valencia until now. She is working in toxicity in developmental and neurodegenerative disease (such as Alzheimer’s disease) looking for oxidative stress and inflammation mechanisms.
David has worked in community based mental health services in the UK for over thirty years developing services for people with complex care needs and enduring mental health problems in a career spanning the voluntary sector, local authority services, and the NHS.. From 2009 - 2011 he was the Dementia Implementation Lead for Commissioning Support for London, working with commissioners across London to improve dementia services. He is an independent writer and researcher on dementia support and services for Black and minority ethnic communities, working with a number of projects and initiatives
Dr. Matevz Leskovsek has earned his PhD degree from University of Ljubljana in 2014 and has since been specializing in T cell, IL cell and TLR cell modulated immune responses in asthma and their pharmacological suppressive agents with main focus on long term effects of short acting beta2-adrenoceptor agonists. Dr Matevz Leskovsek is working at Breathing Labs, Slovenia where he is running a diverse team of researchers performing and publishing in fields of immunology, neurology, and vaccines. He is also a pioneer scientist in the field of electroporation assisted DNA vaccination which is based on a gene-electrotransfer phenomena that has been shown to enhance DNA vaccine efficacy up to three orders of magnitude and to achieve responses comparable to those achieved with protein vaccines.
Dr Foteini Kounti has completed her PhD in Cognitive psychology in the Aristotle University of Thessaloniki, Greece. She is a Cognitive neuropsychologist and the dementia lead of BRINA,-Brains In Action UK. She has co-authored 9 books in relation to older people, dementia diagnosis, cognitive training and care giving topics. Also, Dr Kounti has designed and tested more than 20 different cognitive training programs for older people aiming in dementia prevention and delay. She has delivered 27 publications in prestigious scientific journals worldwide. She had been the dementia lead of 4 day Clinics operating under the Greek Ministry of Health and the Greek Alzheimer’s Disease Association. Since 1995 she co-founded, and has been serving as a board member of, the Alzheimer’s Disease Association and later the Federation of Alzheimer’s disease in Greece.
Ms Myrto Zafeiropoulou has completed her Bsc in psychology at the Empire State University of New York, USA. She is a Cognitive therapist and the CEO of BRINA,-Brains In Action UK. She has been trained in neuropsychological assessment and worked as an assessor for 12 years. In addition, she has been involved in two clinical trial studies both associated with dementia for pharmaceutical companies through Kings College University. She has served as the coordinator of the ‘Care Home Research Network’ at the Institute of Psychiatry, Psychology & Neuroscience, Wolfson Centre for Age-Related Diseases, Kings College University. Also, she has participated in various standardization projects of neuropsychological scales in regards to the diagnosis of dementia and mild cognitive impairment. She has delivered 3 publications in prestigious scientific journals worldwide.
Nataliia O. Melnyk - the Professor of the Histology and Embryology Department of National O.O.Bogomolets Medical University, the Leading Research Scientist of the Experimental Modeling Laboratory at the State Institute of Genetic and Regenerative Medicine National Academy of Medical Sciences of Ukraine, Kyiv. Graduated from Kyiv National Taras Shevchenko University in 1993, after an assignment she worked as an engineer in the Institute of Molecular Biology and Genetics. During 2008- 2011, she worked as Deputy Head of the Department of Education and Methodology of the National O.O.Bogomolets Medical University. She has more than 270 scientific and methodological works, 5 patents of scientific research.
Cognitive therapy, Age Related Disorders, Dementia